Fosamax is an oral bisphosphonate intended to help reduce bone loss and fracture risk associated with osteoporosis, typically in postmenopausal women. However, long-term Fosamax use can caus... Read more
Merck & Co. Inc. has agreed to pay $27.7 million to settle hundreds of lawsuits claiming its bone drug Fosamax caused a condition known as osteonecrosis of the jaw (ONJ). The settlement... Read more
Chad Cook, a lawyer in our Mass Torts Section, is currently responsible for a number of cases including Fosamax,Heparin, Reglan and Zithromax litigation. He also assists in investigating new... Read more
A number of Beasley Allen lawyers have been selected by federal judges around the U.S. to serve on the Plaintiffs Steering Committee (PSC) in lawsuits that have been consolidated in Multidis... Read more
Merck, the maker of Fosamax, lost its second bellwether Fosamax side effects lawsuit last month. The drugmaker faces thousands of lawsuits in state and federal court alleging a link between... Read more
Our Mass Torts Section has been very busy over the past several months. Lawyers and staff personnel are currently involved in litigation involving a number of medications and devices. Some o... Read more
The Fosamax litigation is about to start a new chapter. The first Fosamax lawsuit was filed about six years ago. As we have previously reported, suits against Merck, the drug’s manufacturer,... Read more
Although much of the focus on bisphosphonate side effects has been on Fosamax, bisphosphonate lawsuits have been filed regarding other medications, including Zometa. One such lawsuit recentl... Read more
A special settlement master has been appointed in the Fosamax multidistrict litigation. John D. Feerick, a law professor at Fordham University School of Law in New York, was appointed by U.S... Read more
Chad Cook, a lawyer in our Mass Torts Section, has been heavily involved in the Fosamax, Heparin, Reglan and Zithromax litigation. Chad also assists in investigating new drugs and medical de... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.